<DOC>
	<DOCNO>NCT02626572</DOCNO>
	<brief_summary>The purpose trial ass efficacy safety S47445 versus placebo patient Alzheimer 's disease mild moderate stage depressive symptom . An optional 28-week extension period perform evaluate safety/tolerance efficacy S47445 co-administration donepezil .</brief_summary>
	<brief_title>Efficacy Safety 3 Doses S47445 Versus Placebo Patients With Alzheimer 's Disease Mild Moderate Stages With Depressive Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Depression</mesh_term>
	<criteria>Outpatients Able perform neuropsychological test Have responsible informant DSMIVTR criterion Dementia Alzheimer 's Disease Type Mini mental State Examination ( MMSE ) = 1524 inclusive National Institute Mental Health ( NIMH ) provisional criterion depression AD ( NIMHdAD ) Cornell Scale Depression Dementia total score &gt; = 8 Patients never treat AD treatment patient stop AD treatment whatever reason Patients either currently treat antidepressant patient treat antidepressant recommend dose least 8 week without clinical efficacy , stop treatment accord investigator 's opinion . Patients able read write Patients participate study test disease modify therapy AD , another study administration investigational drug device within previous 3 month prior selection visit Depressive symptom , investigator 's judgment , clearly due medical condition AD , direct result nonmood relate dementia symptom History epilepsy solitary seizure Medical history Major Depressive Disorder 3 year onset disease , treat antidepressive drug electroconvulsive therapy Severe unstable disease type could interfere safety efficacy assessment Alcohol abuse drug abuse addiction , judge clinician ( exclude nicotine ) Clinically relevant lactose intolerance Antidepressant treatment stop least 3 week inclusion Significant worsen depressive symptom high suicidal risk accord investigator 's judgment For optional extension phase : medically instable Chronic Obstructive Pulmonary Disease asthma , know hypersensitivity donepezil hydrochloride piperidine derivative</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>